SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040631
Filing Date
2023-08-09
Accepted
2023-08-09 16:20:33
Documents
77
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acet-20230630.htm   iXBRL 10-Q 2626284
2 EX-10.2 acet-ex10_2.htm EX-10.2 119656
3 EX-31.1 acet-ex31_1.htm EX-31.1 19409
4 EX-31.2 acet-ex31_2.htm EX-31.2 19668
5 EX-32.1 acet-ex32_1.htm EX-32.1 15809
  Complete submission text file 0000950170-23-040631.txt   9269815

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20230630_pre.xml EX-101.PRE 424649
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acet-20230630_cal.xml EX-101.CAL 53675
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acet-20230630_def.xml EX-101.DEF 249131
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20230630_lab.xml EX-101.LAB 560764
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20230630.xsd EX-101.SCH 76422
71 EXTRACTED XBRL INSTANCE DOCUMENT acet-20230630_htm.xml XML 1492790
Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38359 | Film No.: 231155498
SIC: 2834 Pharmaceutical Preparations